OncoTherapy Science Balance Sheet Health
Financial Health criteria checks 6/6
OncoTherapy Science has a total shareholder equity of ¥655.0M and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥931.0M and ¥276.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥598.00m |
Equity | JP¥655.00m |
Total liabilities | JP¥276.00m |
Total assets | JP¥931.00m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4564's short term assets (¥881.0M) exceed its short term liabilities (¥227.0M).
Long Term Liabilities: 4564's short term assets (¥881.0M) exceed its long term liabilities (¥49.0M).
Debt to Equity History and Analysis
Debt Level: 4564 is debt free.
Reducing Debt: 4564 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4564 has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 4564 is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.